Steroid initiation dose and duration of steroid reduction for immune checkpoint inhibitor‐induced liver injury

In some patients with severe ICI-induced liver injury, a dose of 0.8 mg/kg/day of PSL is sufficient to achieve a therapeutic effect and shorten the time required to reduce the dose to 10 mg/day.

Authors

Institutions

Publication Details

Journal
Hepatology Research
Published
2025-05-14
DOI
https://doi.org/10.1111/hepr.14200
Citations
1
Primary Topic
Cancer Immunotherapy and Biomarkers
Type
article
Field-Weighted Citation Impact
1.05
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
article

Steroid initiation dose and duration of steroid reduction for immune checkpoint inhibitor‐induced liver injury

Takashi Honda, Takafumi Yamamoto, Shinya Yokoyama, Takanori Ito et al.
1 citations
Hepatology Research
Cancer Immunotherapy and Biomarkers
1.05
article

Steroid initiation dose and duration of steroid reduction for immune checkpoint inhibitor‐induced liver injury

Takashi Honda, Takafumi Yamamoto, Shinya Yokoyama, Takanori Ito, Kazuyuki Mizuno, Hiroki Kawashima, Kenta Yamamoto, Yoji Ishizu, Norihiro Imai, Takaya Suzuki
article en
1 citations

Abstract

In some patients with severe ICI-induced liver injury, a dose of 0.8 mg/kg/day of PSL is sufficient to achieve a therapeutic effect and shorten the time required to reduce the dose to 10 mg/day.

Hepatology ResearchVol. 55(7)
Nagoya University Hospital (JP), Nagoya University (JP)
Good health and well-being
Openalex Percentile: Top 22%
Cancer Immunotherapy and Biomarkers
1.05
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.